1. Home
  2. PYN vs PYPD Comparison

PYN vs PYPD Comparison

Compare PYN & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PYN
  • PYPD
  • Stock Information
  • Founded
  • PYN 2002
  • PYPD 2008
  • Country
  • PYN United States
  • PYPD Israel
  • Employees
  • PYN N/A
  • PYPD N/A
  • Industry
  • PYN Investment Managers
  • PYPD Medical/Dental Instruments
  • Sector
  • PYN Finance
  • PYPD Health Care
  • Exchange
  • PYN Nasdaq
  • PYPD Nasdaq
  • Market Cap
  • PYN 34.5M
  • PYPD 29.1M
  • IPO Year
  • PYN N/A
  • PYPD 2020
  • Fundamental
  • Price
  • PYN $5.85
  • PYPD $2.90
  • Analyst Decision
  • PYN
  • PYPD Strong Buy
  • Analyst Count
  • PYN 0
  • PYPD 2
  • Target Price
  • PYN N/A
  • PYPD $10.50
  • AVG Volume (30 Days)
  • PYN 19.9K
  • PYPD 26.3K
  • Earning Date
  • PYN 01-01-0001
  • PYPD 02-12-2025
  • Dividend Yield
  • PYN 5.07%
  • PYPD N/A
  • EPS Growth
  • PYN N/A
  • PYPD N/A
  • EPS
  • PYN N/A
  • PYPD N/A
  • Revenue
  • PYN N/A
  • PYPD N/A
  • Revenue This Year
  • PYN N/A
  • PYPD N/A
  • Revenue Next Year
  • PYN N/A
  • PYPD N/A
  • P/E Ratio
  • PYN N/A
  • PYPD N/A
  • Revenue Growth
  • PYN N/A
  • PYPD N/A
  • 52 Week Low
  • PYN $4.84
  • PYPD $2.37
  • 52 Week High
  • PYN $6.60
  • PYPD $7.00
  • Technical
  • Relative Strength Index (RSI)
  • PYN 60.65
  • PYPD 44.51
  • Support Level
  • PYN $5.68
  • PYPD $2.88
  • Resistance Level
  • PYN $5.77
  • PYPD $3.48
  • Average True Range (ATR)
  • PYN 0.04
  • PYPD 0.28
  • MACD
  • PYN 0.02
  • PYPD -0.02
  • Stochastic Oscillator
  • PYN 89.47
  • PYPD 19.58

About PYN PIMCO New York Municipal Income Fund III of Beneficial Interest

PIMCO New York Municipal Income Fund III is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State, and New York City income tax. To pursue the objectives, the fund invests a majority of its net assets in municipal bonds that pay interest that is exempt from federal, New York State, and New York City income tax.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: